Neofordex 40 mg Oral Solution
PDF Leaflet Revision Date: 19 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of symptomatic multiple myeloma in adults.
Dosage (summary)
40 mg once daily; lower doses may be considered for elderly or frail patients.
Special Populations
- Elderly
- Hepatic impairment
- Renal insufficiency
Pregnancy & Breastfeeding
May cause congenital malformations; contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Live attenuated vaccines
- Ciclosporin
- NSAIDs
- Hypokalaemic medicines
Contraindications
- Hypersensitivity to dexamethasone
- Active viral disease
- Uncontrolled psychoses
- Active tuberculosis
Common side effects
- Hyperglycaemia
- Insomnia
- Pneumonia
- Neutropenia
- Thrombocytopenia
Counselling Points
- Take in the morning to minimize insomnia
- Monitor for signs of infection
- Avoid contact with chickenpox or measles
- Report any psychiatric symptoms
Serious warnings
- Risk of serious infections
- Psychiatric disorders
- Tumour lysis syndrome
- Gastrointestinal disorders
Important Disclaimer
The Neofordex 40 mg Oral Solution professional information leaflet below is the property of Key Oncologics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
